Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.480
-0.110 (-4.25%)
Apr 16, 2026, 1:34 PM EDT - Market open
Century Therapeutics Employees
Century Therapeutics had 78 employees as of December 31, 2025. The number of employees decreased by 72 or -48.00% compared to the previous year.
Employees
78
Change (1Y)
-72
Growth (1Y)
-48.00%
Revenue / Employee
$1,399,538
Profits / Employee
-$122,821
Market Cap
445.71M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 78 | -72 | -48.00% | 78 | 0 |
| Dec 31, 2024 | 150 | -15 | -9.09% | 140 | 10 |
| Dec 31, 2023 | 165 | -19 | -10.33% | 152 | 13 |
| Dec 31, 2022 | 184 | -4 | -2.13% | 163 | 21 |
| Dec 31, 2021 | 188 | 81 | 75.70% | 170 | 18 |
| Jun 30, 2021 | 121 | - | - | 121 | 0 |
| Mar 31, 2021 | 107 | - | - | 97 | 10 |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Vanda Pharmaceuticals | 533 |
| Rocket Pharmaceuticals | 202 |
| Enanta Pharmaceuticals | 120 |
| Zentalis Pharmaceuticals | 106 |
| Altimmune | 57 |
| PureTech Health | 56 |
| Climb Bio | 29 |
IPSC News
- 7 weeks ago - Century Therapeutics to Participate in Upcoming Investor Conferences in March - GlobeNewsWire
- 2 months ago - IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewsWire
- 5 months ago - Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 5 months ago - Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes - GlobeNewsWire
- 6 months ago - Century Therapeutics to Present at Chardan's 9th Annual Genetic Medicines Conference - GlobeNewsWire
- 8 months ago - Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 8 months ago - Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire